COVID - 19 Vaccination Update - Day 505 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 04 JUN 2022 8:53 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 194 Crore landmark milestone (194,07,80,539) today. More than 10 lakh (10,28,295) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10407257
	2^nd Dose	10043381
	Precaution Dose	5296809
FLWs	1^st Dose	18419758
	2^nd Dose	17589633
	Precaution Dose	8915467
Age Group 12-14 years	1^st Dose	34410528
	2^nd Dose	17614478
Age Group 15-18 years	1^st Dose	59600158
	2^nd Dose	46191805
Age Group 18-44 years	1^st Dose	557325286
	2^nd Dose	491705752
	Precaution Dose	1088960
Age Group 45-59 years	1^st Dose	203280987
	2^nd Dose	191223144
	Precaution Dose	1539316
Over 60 years	1^st Dose	127114243
	2^nd Dose	119288546
	Precaution Dose	19725031
Cumulative 1^st dose administered		1010558217
Cumulative 2^nd dose administered		893656739
Precaution Dose		36565583
Total		1940780539

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 4^th June, 2022 (505^th Day)
HCWs	1^st Dose	24
	2^nd Dose	570
	Precaution Dose	12793
FLWs	1^st Dose	85
	2^nd Dose	849
	Precaution Dose	32603
Age Group 12-14 years	1^st Dose	79579
	2^nd Dose	190058
Age Group 15-18 years	1^st Dose	20916
	2^nd Dose	69021
Age Group 18-44 years	1^st Dose	27672
	2^nd Dose	252933
	Precaution Dose	66722
Age Group 45-59 years	1^st Dose	4833
	2^nd Dose	56297
	Precaution Dose	37573
Over 60 years	1^st Dose	4233
	2^nd Dose	38242
	Precaution Dose	133292
Cumulative 1^st dose administered		137342
Cumulative 2^nd dose administered		607970
Precaution Dose		282983
Total		1028295

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.